Author: Joe Martin, PBC Communications
-
Flinn Foundation provides three-year grant to CEI for biosciences training
The Flinn Foundation recently announced it had awarded the Center for Entrepreneurial Innovation from Gateway Community college more than $350,000 over three years to support CEI’s LabForce professional development center on the Phoenix Bioscience Core.
-
In the Neighborhood: What are those buildings going up around the PBC?
The skyline around the Phoenix Bioscience Core is changing big-time. As you go about your daily routine at the PBC, have you wondered what those multi-story cranes and workers in lime-colored vests are constructing? Courtesy of AZ Big Media, here’s a recap of your new (building) neighbors.
-
Study involving TGen, City of Hope uses DNA in the bloodstream to guide treatment for cancer patients
TGen and City of Hope investigators Kamel Lahouel and Cristian Tomasetti are working on study to help guide cancer treatment.
-
The Commons podcast from Wexford Science + Technology examines the Phoenix Bioscience Core
Taking a roadtrip or have a lengthy commute to work? We have a great podcast rec for you. As part of the Wexford Science + Technology’s podcast “The Commons”, Executive Vice President Tom Osha sat down with industry and city leaders in 2020 to talk about the future of Phoenix as a life science hub,…
-
City of Phoenix makes pitch as emerging life science hub to the world at BIO International
A delegation of leaders from the city of Phoenix and members of the Phoenix Bioscience Core community visited San Diego this week for BIO International 2022, the world’s largest convening […]
-
PBC Company Calviri announces enrollment of 800 dogs in preventative cancer vaccine trial
Vaccine Against Canine Cancer Study (VACCS), with 800 dogs, making it the largest interventional canine clinical trial in the history of veterinary medicine.
-
TGen-Temple review suggests even normal weight individuals are susceptible to severe fatty liver disease
Severe fatty liver disease is commonly associated with obesity, but according to a review of scientific literature conducted by researchers at Temple University and the Translational Genomics Research Institute (TGen), an […]
-
Calviri CEO Dr. Stephen Johnston on cancer eradication
Phoenix Bioscience Core-based Calviri Inc.’s founder Dr. Stephen Johnston recently spoke to Progress, Potential and Possibilities on eradicating cancer via a universival preventative cancer vaccine.
-
TGen study allows late-stage cancer patients to use their health data to guide care
A unique study pairing researchers from the Translational Genomics Research Institute (TGen), part of City of Hope, with one cancer patient is now underway to help answer that question. Rick Stanton, a former engineer and advanced prostate cancer patient, is at the center of TGen’s Patient Engagements, Operational Practices, and Laboratory Environment Standardization (PEOPLES) protocol.
-
Phoenix Mayor Kate Gallego discusses Phoenix Bioscience Core, growth of life science industry in Phoenix
Development Director Christine Mackay recently spoke to Arizona PBS about the growth of the Phoenix Bioscience Core and the city’s life science industry as a whole. Speaking to Arizona Horizon, Mayor Gallego noted how Phoenix has become a hot spot for life science companies from around the world.
